IPO Year: 2024
Exchange: NASDAQ
| Date | Price Target | Rating | Analyst |
|---|---|---|---|
| 5/7/2024 | $10.00 | Buy | H.C. Wainwright |
| 5/2/2024 | $16.00 → $6.00 | Overweight → Neutral | JP Morgan |
| 3/5/2024 | Outperform | TD Cowen | |
| 3/5/2024 | $22.00 | Outperform | BMO Capital Markets |
| 3/5/2024 | $16.00 | Overweight | JP Morgan |
| 3/5/2024 | $23.00 | Buy | Jefferies |
| 3/5/2024 | $21.00 | Buy | Chardan Capital Markets |
| 3/5/2024 | $25.00 | Overweight | Wells Fargo |
8-K - Metagenomi, Inc. (0001785279) (Filer)
10-Q - Metagenomi, Inc. (0001785279) (Filer)
8-K - Metagenomi, Inc. (0001785279) (Filer)
DEFA14A - Metagenomi, Inc. (0001785279) (Filer)
DEF 14A - Metagenomi, Inc. (0001785279) (Filer)
EFFECT - Metagenomi, Inc. (0001785279) (Filer)
8-K - Metagenomi, Inc. (0001785279) (Filer)
S-3 - Metagenomi, Inc. (0001785279) (Filer)
S-8 - Metagenomi, Inc. (0001785279) (Filer)
8-K - Metagenomi, Inc. (0001785279) (Filer)
H.C. Wainwright initiated coverage of Metagenomi with a rating of Buy and set a new price target of $10.00
JP Morgan downgraded Metagenomi from Overweight to Neutral and set a new price target of $6.00 from $16.00 previously
TD Cowen initiated coverage of Metagenomi with a rating of Outperform
BMO Capital Markets initiated coverage of Metagenomi with a rating of Outperform and set a new price target of $22.00
JP Morgan initiated coverage of Metagenomi with a rating of Overweight and set a new price target of $16.00
Jefferies initiated coverage of Metagenomi with a rating of Buy and set a new price target of $23.00
Chardan Capital Markets initiated coverage of Metagenomi with a rating of Buy and set a new price target of $21.00
Wells Fargo initiated coverage of Metagenomi with a rating of Overweight and set a new price target of $25.00